You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
McKesson
McKinsey
Johnson and Johnson
Baxter
Harvard Business School

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 5,795,891

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,795,891
Title: Acylphenylglycine derivative and preventive and remedy for diseases caused by increased collagenase activity containing said compound as active ingredient
Abstract:An acylphenylglycine derivative represented by general formula (I) or a pharmaceutically acceptable salt thereof, and a preventive and remedy for diseases caused by an increased collagenase activity containing the same as the active ingredient, wherein R.sup.1 represents hydrogen atom, methyl, methylaminomethyl or morpholinomethyl; R.sup.2 represents hydrogen atom, hydroxy, fluorine atom, or C.sub.1 -C.sub.4 linear or branched alkyl; and R.sup.3 represents C.sub.1 -C.sub.4 linear or branched alkyl. The compound (I) and the salt maintains a potent collagenase inhibitor activity in the blood for long after being administered, and are useful as a remedy for various diseases believed to be caused by an increased collagenase activity. ##STR1##
Inventor(s): Hirayama; Ryoichi (Akashi, JP), Tsukida; Takahiro (Osaka, JP), Yamamoto; Minoru (Osaka, JP), Ikeda; Shoji (Kobe, JP), Sakamoto; Fumio (Daito, JP), Obata; Yuji (Osaka, JP), Matsuo; Konomi (Osaka, JP)
Assignee: Kanebo Ltd. (Tokyo, JP)
Application Number:08/596,278
Patent Claims:see list of patent claims

Details for Patent 5,795,891

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial Kanebo Ltd. (Tokyo, JP) 2013-08-09 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
McKesson
Merck
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.